ERBB2 and breast neoplasm: In contrast, CDYL2b was mainly upregulated in luminal and HER2-positive breast tumors relative to TNBC tumors (Figure 1D), which is consistent with the expression pattern of CDYL2 in the TCGA database (Figure S4C).